Marshall University
Dexmedetomidine adjunctive ketamine to enhance attenuation of methamphetamine-induced agitation
Abstract
dc:description.abstractAgitation caused by methamphetamine (METH) use is a common and serious issue in emergency settings. While sedatives like benzodiazepines are often used, they can be dangerous, especially when breathing is already compromised due to METH-opioid co-exposure. Dexmedetomidine (DEXMED) is a safer alternative that provides sedation without major effects on breathing, but it can lower heart rate and blood pressure when used at high doses. This thesis project focused on finding whether combining low-dose DEXMED with ketamine (KET) can safely and effectively manage METH-induced agitation in a rat model. Using METH to trigger hyperactivity, we will test whether this combination could reduce agitation and offer better sedation than DEXMED alone while possibly yielding a more so ideal side effect profile than that of higher DEXMED doses.
Degree
thesis:*- Name thesis:degree_name
- Pharmaceutical Sciences
- Level thesis:degree_level
- Thesis
- Discipline thesis:degree_discipline
- School of Pharmacy
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Budamkayala, Madhuri
- Contributors dc:contributor
-
- Dr. Michael Hambuchen
- Dr. Cynthia B Jones
- Dr. Eric Blough
Subjects
dc:subject × 8Identifiers
dc:identifier.*- Repository record dc:identifier
- https://mds.marshall.edu/etd/1998